| Schedule of Revenue |
Revenue for the year ended December 31, 2025,
consists of the following:
| | |
Corporate
Customers | | |
Retail
Customers | | |
Total | |
| Medical and related products | |
$ | 280,719 | | |
$ | 55 | | |
$ | 280,774 | |
| Drugs | |
| 209,025 | | |
| 14,400 | | |
| 223,425 | |
| Beauty products | |
| 49,841 | | |
| 70 | | |
| 49,911 | |
| Contact lenses | |
| 35,000 | | |
| — | | |
| 35,000 | |
| Nutritional products | |
| 5,000 | | |
| 234 | | |
| 5,234 | |
| Supplements | |
| 2,405 | | |
| 68 | | |
| 2,473 | |
| Total | |
$ | 581,990 | | |
$ | 14,827 | | |
$ | 596,817 | |
Revenue for the year ended December 31, 2024,
consists of the following:
| | |
Corporate
Customers | | |
Retail
Customers | | |
Total | |
| Drugs | |
$ | 143,633 | | |
$ | — | | |
$ | 143,633 | |
| Medical and related products | |
| 292,609 | | |
| 249 | | |
| 292,858 | |
| Nutritional products | |
| 41,458 | | |
| 314 | | |
| 41,772 | |
| Supplements | |
| 24,057 | | |
| 8,040 | | |
| 32,097 | |
| Total | |
$ | 501,757 | | |
$ | 8,603 | | |
$ | 510,360 | |
Revenue for the years ended December 31, 2023,
consists of the following:
| | |
Corporate
Customers | | |
Retail
Customers | | |
Total | |
| Drugs | |
$ | 141,947 | | |
$ | — | | |
$ | 141,947 | |
| Medical and related products | |
| 146,593 | | |
| 257 | | |
| 146,850 | |
| Nutritional products | |
| 5,934 | | |
| 3,606 | | |
| 9,540 | |
| Supplements | |
| 32,341 | | |
| 19,453 | | |
| 51,794 | |
| Total | |
$ | 326,815 | | |
$ | 23,316 | | |
$ | 350,131 | |
|